Global Lercanidipine API Market Research Report 2025

Publication ID:

PB501255060

Publication Date:

February 5, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Lercanidipine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lercanidipine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lercanidipine API.
The Lercanidipine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lercanidipine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lercanidipine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chongqing Shenghuaxi Pharmaceutical
Guangzhou Tosun Pharmaceutical
Fuan Pharmaceutical
Metrochem API Private Limited
Fareva
Octavius Pharma Pvt. Ltd
Piramal Pharma Solutions
CTX Lifesciences
Hetero Drugs
MSN Laboratories
Shouyuan Chemical
Sun Pharmaceutical Industries Limited
Unipex
by Type
0.98
0.99
Others
by Application
Medical Pharmaceutical
Scientific Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lercanidipine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Lercanidipine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Lercanidipine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Lercanidipine API Market Overview
1.1 Product Definition
1.2 Lercanidipine API by Type
1.2.1 Global Lercanidipine API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Lercanidipine API by Application
1.3.1 Global Lercanidipine API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Medical Pharmaceutical
1.3.3 Scientific Research
1.4 Global Market Growth Prospects
1.4.1 Global Lercanidipine API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Lercanidipine API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Lercanidipine API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Lercanidipine API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lercanidipine API Production Market Share by Manufacturers (2020-2025)
2.2 Global Lercanidipine API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Lercanidipine API, Industry Ranking, 2023 VS 2024
2.4 Global Lercanidipine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Lercanidipine API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Lercanidipine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Lercanidipine API, Product Offered and Application
2.8 Global Key Manufacturers of Lercanidipine API, Date of Enter into This Industry
2.9 Lercanidipine API Market Competitive Situation and Trends
2.9.1 Lercanidipine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Lercanidipine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Lercanidipine API Production by Region
3.1 Global Lercanidipine API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Lercanidipine API Production Value by Region (2020-2031)
3.2.1 Global Lercanidipine API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Lercanidipine API by Region (2026-2031)
3.3 Global Lercanidipine API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Lercanidipine API Production Volume by Region (2020-2031)
3.4.1 Global Lercanidipine API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Lercanidipine API by Region (2026-2031)
3.5 Global Lercanidipine API Market Price Analysis by Region (2020-2025)
3.6 Global Lercanidipine API Production and Value, Year-over-Year Growth
3.6.1 North America Lercanidipine API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Lercanidipine API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Lercanidipine API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Lercanidipine API Production Value Estimates and Forecasts (2020-2031)
4 Lercanidipine API Consumption by Region
4.1 Global Lercanidipine API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Lercanidipine API Consumption by Region (2020-2031)
4.2.1 Global Lercanidipine API Consumption by Region (2020-2025)
4.2.2 Global Lercanidipine API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Lercanidipine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Lercanidipine API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lercanidipine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Lercanidipine API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lercanidipine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Lercanidipine API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lercanidipine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Lercanidipine API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Lercanidipine API Production by Type (2020-2031)
5.1.1 Global Lercanidipine API Production by Type (2020-2025)
5.1.2 Global Lercanidipine API Production by Type (2026-2031)
5.1.3 Global Lercanidipine API Production Market Share by Type (2020-2031)
5.2 Global Lercanidipine API Production Value by Type (2020-2031)
5.2.1 Global Lercanidipine API Production Value by Type (2020-2025)
5.2.2 Global Lercanidipine API Production Value by Type (2026-2031)
5.2.3 Global Lercanidipine API Production Value Market Share by Type (2020-2031)
5.3 Global Lercanidipine API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Lercanidipine API Production by Application (2020-2031)
6.1.1 Global Lercanidipine API Production by Application (2020-2025)
6.1.2 Global Lercanidipine API Production by Application (2026-2031)
6.1.3 Global Lercanidipine API Production Market Share by Application (2020-2031)
6.2 Global Lercanidipine API Production Value by Application (2020-2031)
6.2.1 Global Lercanidipine API Production Value by Application (2020-2025)
6.2.2 Global Lercanidipine API Production Value by Application (2026-2031)
6.2.3 Global Lercanidipine API Production Value Market Share by Application (2020-2031)
6.3 Global Lercanidipine API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Chongqing Shenghuaxi Pharmaceutical
7.1.1 Chongqing Shenghuaxi Pharmaceutical Lercanidipine API Company Information
7.1.2 Chongqing Shenghuaxi Pharmaceutical Lercanidipine API Product Portfolio
7.1.3 Chongqing Shenghuaxi Pharmaceutical Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Chongqing Shenghuaxi Pharmaceutical Main Business and Markets Served
7.1.5 Chongqing Shenghuaxi Pharmaceutical Recent Developments/Updates
7.2 Guangzhou Tosun Pharmaceutical
7.2.1 Guangzhou Tosun Pharmaceutical Lercanidipine API Company Information
7.2.2 Guangzhou Tosun Pharmaceutical Lercanidipine API Product Portfolio
7.2.3 Guangzhou Tosun Pharmaceutical Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.2.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
7.3 Fuan Pharmaceutical
7.3.1 Fuan Pharmaceutical Lercanidipine API Company Information
7.3.2 Fuan Pharmaceutical Lercanidipine API Product Portfolio
7.3.3 Fuan Pharmaceutical Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Fuan Pharmaceutical Main Business and Markets Served
7.3.5 Fuan Pharmaceutical Recent Developments/Updates
7.4 Metrochem API Private Limited
7.4.1 Metrochem API Private Limited Lercanidipine API Company Information
7.4.2 Metrochem API Private Limited Lercanidipine API Product Portfolio
7.4.3 Metrochem API Private Limited Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Metrochem API Private Limited Main Business and Markets Served
7.4.5 Metrochem API Private Limited Recent Developments/Updates
7.5 Fareva
7.5.1 Fareva Lercanidipine API Company Information
7.5.2 Fareva Lercanidipine API Product Portfolio
7.5.3 Fareva Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Fareva Main Business and Markets Served
7.5.5 Fareva Recent Developments/Updates
7.6 Octavius Pharma Pvt. Ltd
7.6.1 Octavius Pharma Pvt. Ltd Lercanidipine API Company Information
7.6.2 Octavius Pharma Pvt. Ltd Lercanidipine API Product Portfolio
7.6.3 Octavius Pharma Pvt. Ltd Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Octavius Pharma Pvt. Ltd Main Business and Markets Served
7.6.5 Octavius Pharma Pvt. Ltd Recent Developments/Updates
7.7 Piramal Pharma Solutions
7.7.1 Piramal Pharma Solutions Lercanidipine API Company Information
7.7.2 Piramal Pharma Solutions Lercanidipine API Product Portfolio
7.7.3 Piramal Pharma Solutions Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Piramal Pharma Solutions Main Business and Markets Served
7.7.5 Piramal Pharma Solutions Recent Developments/Updates
7.8 CTX Lifesciences
7.8.1 CTX Lifesciences Lercanidipine API Company Information
7.8.2 CTX Lifesciences Lercanidipine API Product Portfolio
7.8.3 CTX Lifesciences Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 CTX Lifesciences Main Business and Markets Served
7.8.5 CTX Lifesciences Recent Developments/Updates
7.9 Hetero Drugs
7.9.1 Hetero Drugs Lercanidipine API Company Information
7.9.2 Hetero Drugs Lercanidipine API Product Portfolio
7.9.3 Hetero Drugs Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Hetero Drugs Main Business and Markets Served
7.9.5 Hetero Drugs Recent Developments/Updates
7.10 MSN Laboratories
7.10.1 MSN Laboratories Lercanidipine API Company Information
7.10.2 MSN Laboratories Lercanidipine API Product Portfolio
7.10.3 MSN Laboratories Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 MSN Laboratories Main Business and Markets Served
7.10.5 MSN Laboratories Recent Developments/Updates
7.11 Shouyuan Chemical
7.11.1 Shouyuan Chemical Lercanidipine API Company Information
7.11.2 Shouyuan Chemical Lercanidipine API Product Portfolio
7.11.3 Shouyuan Chemical Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Shouyuan Chemical Main Business and Markets Served
7.11.5 Shouyuan Chemical Recent Developments/Updates
7.12 Sun Pharmaceutical Industries Limited
7.12.1 Sun Pharmaceutical Industries Limited Lercanidipine API Company Information
7.12.2 Sun Pharmaceutical Industries Limited Lercanidipine API Product Portfolio
7.12.3 Sun Pharmaceutical Industries Limited Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Sun Pharmaceutical Industries Limited Main Business and Markets Served
7.12.5 Sun Pharmaceutical Industries Limited Recent Developments/Updates
7.13 Unipex
7.13.1 Unipex Lercanidipine API Company Information
7.13.2 Unipex Lercanidipine API Product Portfolio
7.13.3 Unipex Lercanidipine API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Unipex Main Business and Markets Served
7.13.5 Unipex Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lercanidipine API Industry Chain Analysis
8.2 Lercanidipine API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lercanidipine API Production Mode & Process Analysis
8.4 Lercanidipine API Sales and Marketing
8.4.1 Lercanidipine API Sales Channels
8.4.2 Lercanidipine API Distributors
8.5 Lercanidipine API Customer Analysis
9 Lercanidipine API Market Dynamics
9.1 Lercanidipine API Industry Trends
9.2 Lercanidipine API Market Drivers
9.3 Lercanidipine API Market Challenges
9.4 Lercanidipine API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Chongqing Shenghuaxi Pharmaceutical
Guangzhou Tosun Pharmaceutical
Fuan Pharmaceutical
Metrochem API Private Limited
Fareva
Octavius Pharma Pvt. Ltd
Piramal Pharma Solutions
CTX Lifesciences
Hetero Drugs
MSN Laboratories
Shouyuan Chemical
Sun Pharmaceutical Industries Limited
Unipex

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂